Patents by Inventor FLORIAN SALIPANTE

FLORIAN SALIPANTE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKER COMBINATIONS TO SIMULTANEOUSLY EVALUATE NON-ALCOHOLIC STEATOHEPATITIS AND HEPATIC FIBROSIS STATUS
    Publication number: 20240094223
    Abstract: The invention provides a method of diagnosing Non-Alcoholic Steatohepatitis (NASH) and/or the hepatic fibrosis status of a subject, especially a subject afflicted with Non-alcoholic fatty liver disease (NAFLD) or NASH, based on the level of only three or more particular biomarkers. The invention further provides a kit suitable for performing said method and the use of said method and methods of treating patients diagnosed in accordance with the disclosed methods.
    Type: Application
    Filed: November 6, 2023
    Publication date: March 21, 2024
    Inventors: ISABELLE BATXELLI-MOLINA, FLORIAN SALIPANTE, ROGER P. WALKER, JOHN FLANAGAN, JEANNETTE FAREH-MICHIEL
  • OPTIMAL COMBINATION OF EARLY BIOMARKERS FOR INFECTION AND SEPSIS DIAGNOSIS IN EMERGENCY DEPARTMENT
    Publication number: 20240036060
    Abstract: The present invention allows a rapid and early diagnosis of bacterial or viral infection. Such a diagnosis is highly desired among patients admitted in emergency department to allow the initiation of the appropriate treatment. Although no biomarker alone can offer an appropriate diagnosis with sufficient sensitivity and specificity, the present invention defines optimal combinations of biomarkers allowing the diagnosis of infection.
    Type: Application
    Filed: October 11, 2021
    Publication date: February 1, 2024
    Inventors: Jean-Marc CAVAILLON, Laetitia VELLY, Pierre HAUSFATER, Catherine FITTING, Stevenn VOLANT, Florian SALIPANTE, Lionel VALERA, Jeannette FAREH
  • Biomarker combinations to simultaneously evaluate non-alcoholic steatohepatitis and hepatic fibrosis status
    Patent number: 11808772
    Abstract: The invention provides a method of diagnosing Non-Alcoholic Steatohepatitis (NASH) and/or the hepatic fibrosis status of a subject, especially a subject afflicted with Non-alcoholic fatty liver disease (NAFLD) or NASH, based on the level of only three or more particular biomarkers. The invention further provides a kit suitable for performing said method and the use of said method and methods of treating patients diagnosed in accordance with the disclosed methods.
    Type: Grant
    Filed: July 19, 2018
    Date of Patent: November 7, 2023
    Inventors: Isabelle Batxelli-Molina, Florian Salipante, Roger P. Walker, John Flanagan, Jeannette Fareh-Michiel
  • BIOMARKER COMBINATIONS TO SIMULTANEOUSLY EVALUATE NON-ALCOHOLIC STEATOHEPATITIS AND HEPATIC FIBROSIS STATUS
    Publication number: 20200249242
    Abstract: The invention provides a method of diagnosing Non-Alcoholic Steatohepatitis (NASH) and/or the hepatic fibrosis status of a subject, especially a subject afflicted with Non-alcoholic fatty liver disease (NAFLD) or NASH, based on the level of only three or more particular biomarkers. The invention further provides a kit suitable for performing said method and the use of said method and methods of treating patients diagnosed in accordance with the disclosed methods.
    Type: Application
    Filed: July 19, 2018
    Publication date: August 6, 2020
    Inventors: ISABELLE BATXELLI-MOLINA, FLORIAN SALIPANTE, ROGER P. WALKER, JOHN FLANAGAN, JEANNETTE FAREH-MICHIEL